{
  "nctId": "NCT03048669",
  "briefTitle": "Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo",
  "officialTitle": "Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo",
  "protocolDocument": {
    "nctId": "NCT03048669",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-05-03",
    "uploadDate": "2025-04-29T10:25",
    "size": 525187,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03048669/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 5053,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-11",
    "completionDate": "2022-06-30",
    "primaryCompletionDate": "2021-06-30",
    "firstSubmitDate": "2017-02-07",
    "firstPostDate": "2017-02-09"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* All women diagnosed with HIV during pregnancy or breastfeeding in the participating maternal and child health (MCH) clinics and initiated on antiretroviral therapy (ART) during the enrollment period\n\nExclusion Criteria:\n\n* Refuse to participate\n* Clinics will be excluded if less than 500 pregnant women (less than 5 HIV-infected pregnant women) registered for antenatal care (ANC) in the clinic in 2015",
    "healthyVolunteers": false,
    "sex": "ALL",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Loss-to-follow-up",
        "description": "the proportion of participants for whom the whereabouts is unknown at the evaluation time",
        "timeFrame": "delivery, six weeks, 12 and 24 weeks postpartum"
      },
      {
        "measure": "Virological suppression",
        "description": "Proportion of participants with undetectable viral load",
        "timeFrame": "delivery, 12 and 24 months postpartum"
      }
    ],
    "secondary": [
      {
        "measure": "Timely Infant HIV diagnosis",
        "description": "Proportion of HIV-exposed infant with an appropriate HIV test result",
        "timeFrame": "delivery, six weeks, 12 and 24 weeks postpartum"
      },
      {
        "measure": "Timely ART initiation",
        "description": "Proportion of HIV-infected participants (mother or infant) initiated on ART within two weeks of diagnosis",
        "timeFrame": "two weeks from HIV diagnosis"
      },
      {
        "measure": "MTCT rates",
        "description": "Proportion of HIV-exposed infant who test positive for HIV",
        "timeFrame": "delivery, six weeks, 12 and 24 weeks postpartum"
      },
      {
        "measure": "Survival",
        "description": "Proportion of participating mothers and infants know to be alive",
        "timeFrame": "delivery, six weeks, 12 and 24 weeks postpartum"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 4,
      "otherCount": 0,
      "totalCount": 6
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 69,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:20.888Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}